312 related articles for article (PubMed ID: 30205997)
21. Predictors of outcome in warfarin-related intracerebral hemorrhage.
Zubkov AY; Mandrekar JN; Claassen DO; Manno EM; Wijdicks EF; Rabinstein AA
Arch Neurol; 2008 Oct; 65(10):1320-5. PubMed ID: 18852345
[TBL] [Abstract][Full Text] [Related]
22. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.
Kuramatsu JB; Gerner ST; Schellinger PD; Glahn J; Endres M; Sobesky J; Flechsenhar J; Neugebauer H; Jüttler E; Grau A; Palm F; Röther J; Michels P; Hamann GF; Hüwel J; Hagemann G; Barber B; Terborg C; Trostdorf F; Bäzner H; Roth A; Wöhrle J; Keller M; Schwarz M; Reimann G; Volkmann J; Müllges W; Kraft P; Classen J; Hobohm C; Horn M; Milewski A; Reichmann H; Schneider H; Schimmel E; Fink GR; Dohmen C; Stetefeld H; Witte O; Günther A; Neumann-Haefelin T; Racs AE; Nueckel M; Erbguth F; Kloska SP; Dörfler A; Köhrmann M; Schwab S; Huttner HB
JAMA; 2015 Feb; 313(8):824-36. PubMed ID: 25710659
[TBL] [Abstract][Full Text] [Related]
23. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
[TBL] [Abstract][Full Text] [Related]
24. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
[TBL] [Abstract][Full Text] [Related]
25. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
Trials; 2015 Sep; 16():393. PubMed ID: 26340977
[TBL] [Abstract][Full Text] [Related]
26. Do the antithrombotic therapy at the time of intracerebral hemorrhage influence clinical outcome? analysis between the difference of antiplatelet and anticoagulant agents and clinical course.
Okada T; Nakase T; Sasaki M; Ishikawa T
J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1781-8. PubMed ID: 24957306
[TBL] [Abstract][Full Text] [Related]
27. Antithrombotic and Statin Prescription After Intracerebral Hemorrhage in the Get With The Guidelines-Stroke Registry.
Murthy SB; Zhang C; Shah S; Schwamm LH; Fonarow GC; Smith EE; Bhatt DL; Ziai WC; Kamel H; Sheth KN
Stroke; 2023 Dec; 54(12):2972-2980. PubMed ID: 37942641
[TBL] [Abstract][Full Text] [Related]
28. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Adachi T; Hoshino H; Takagi M; Fujioka S;
Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
[TBL] [Abstract][Full Text] [Related]
29. Trends in prior antithrombotic medication and risk of in-hospital mortality after spontaneous intracerebral hemorrhage: the J-ICH registry.
Ueno H; Tokugawa J; Saito R; Yamashiro K; Tsutsumi S; Yamamoto M; Ueno Y; Mieno M; Yamamoto T; Hishii M; Yasumoto Y; Maruki C; Kondo A; Urabe T; Hattori N; Arai H; Tanaka R;
Sci Rep; 2024 May; 14(1):12009. PubMed ID: 38796624
[TBL] [Abstract][Full Text] [Related]
30. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
[TBL] [Abstract][Full Text] [Related]
31. Impact of Antiplatelets and Anticoagulants on the Prognosis of Intracerebral Hemorrhage.
Hokari M; Shimbo D; Asaoka K; Uchida K; Itamoto K
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):53-60. PubMed ID: 29103863
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage.
Foerch C; Sitzer M; Steinmetz H; Neumann-Haefelin T
Stroke; 2006 Aug; 37(8):2165-7. PubMed ID: 16809556
[TBL] [Abstract][Full Text] [Related]
33. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
[TBL] [Abstract][Full Text] [Related]
34. Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy.
Franco L; Paciaroni M; Enrico ML; Scoditti U; Guideri F; Chiti A; De Vito A; Terruso V; Consoli D; Vanni S; Giossi A; Manina G; Nitti C; Re R; Sacco S; Cappelli R; Beyer-Westendorf J; Pomero F; Agnelli G; Becattini C
Eur J Intern Med; 2020 May; 75():35-43. PubMed ID: 31955918
[TBL] [Abstract][Full Text] [Related]
35. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
[TBL] [Abstract][Full Text] [Related]
36. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage.
Kuwashiro T; Yasaka M; Itabashi R; Nakagaki H; Miyashita F; Naritomi H; Minematsu K
Cerebrovasc Dis; 2011; 31(2):170-6. PubMed ID: 21135553
[TBL] [Abstract][Full Text] [Related]
37. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
Kellert L; Sykora M; Gumbinger C; Herrmann O; Ringleb PA
Cerebrovasc Dis; 2012; 33(2):135-40. PubMed ID: 22179586
[TBL] [Abstract][Full Text] [Related]
38. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
39. Warfarin use leads to larger intracerebral hematomas.
Flaherty ML; Tao H; Haverbusch M; Sekar P; Kleindorfer D; Kissela B; Khatri P; Stettler B; Adeoye O; Moomaw CJ; Broderick JP; Woo D
Neurology; 2008 Sep; 71(14):1084-9. PubMed ID: 18824672
[TBL] [Abstract][Full Text] [Related]
40. Clinical and radiological course of intracerebral haemorrhage associated with the new non-vitamin K anticoagulants.
von der Brelie C; Doukas A; Naumann R; Dempfle A; Larsen N; Synowitz M; Jansen O; Mehdorn M; Jadik S
Acta Neurochir (Wien); 2017 Jan; 159(1):101-109. PubMed ID: 27873051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
